カテゴリ： Grand View Research, 世界, 医療/バイオ

眼科用医薬品の世界市場：薬物クラス別、疾患別、剤形別、投与経路別、製品タイプ別、地域別

◆英語タイトル：Ophthalmic Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Disease, By Dosage Form, By Route Of Administration, By Product Type, By Region, And Segment Forecasts, 2020 - 2027
◆商品コード：GV20MY062
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2020年2月18日
◆ページ数：193
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥630,700見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥736,700見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥948,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
本調査レポートでは、眼科用医薬品の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、競争分析、薬物クラス別（抗アレルギー、抗VEGF剤、抗炎症、抗緑内障、その他）分析、疾患別（ドライアイ、眼アレルギー、緑内障、眼感染症、網膜疾患、ブドウ膜炎）分析、剤形別（ゲル、点眼液、カプセル剤、錠剤、点眼剤、軟膏）分析、投与経路別分析、製品種類別（処方薬、OTC薬）分析、地域別分析、企業概要などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・競争分析
・眼科用医薬品の世界市場：薬物クラス別（抗アレルギー、抗VEGF剤、抗炎症、抗緑内障、その他）
・眼科用医薬品の世界市場：疾患別（ドライアイ、眼アレルギー、緑内障、眼感染症、網膜疾患、ブドウ膜炎）
・眼科用医薬品の世界市場：剤形別（ゲル、点眼液、カプセル剤、錠剤、点眼剤、軟膏）
・眼科用医薬品の世界市場：投与経路別
・眼科用医薬品の世界市場：製品種類別（処方薬、OTC薬）
・眼科用医薬品の世界市場：地域別
・企業概要
【レポートの概要】

The global ophthalmic drugs market size is expected to reach USD 45.8 billion by 2027, registering a CAGR of 5.0%, according to a new report published by Grand View Research, Inc. Advancements in drug delivery systems are anticipated to drive the overall growth.

In December 2017, Spark Therapeutics received Food and Drug Administration (FDA) approval for the first gene therapy drug in the ophthalmic market-Luxturna (voretigene neparvovec-rzyl). The drug is indicated for ophthalmic diseases associated with RPE65 gene mutation, such as retinitis pigmentosa and Leber’s congenital amaurosis.

Increasing number of strategic mergers, acquisitions, and collaborations make the market for ophthalmic drugs a highly competitive space. However, there is ample scope for consolidation. Premium services and high-volume ancillary value-added businesses deliver supplementary benefits to customers and attract investments in the market. The reimbursement policies for ophthalmic treatment form a diversifying factor in the market.

Companies are constantly launching new products to expand their product portfolio and to attain higher share. For instance, in July 2019, Bausch & Lomb Incorporated announced launch of Ocuvite, an eye vitamin supplement to strengthen the macula for the U.S. market.

Due to increasing awareness of ophthalmic disorders and surge in the demand of these products, ophthalmic drug manufacturers are expanding their presence in the emerging economies by supporting various awareness campaigns in different regions. For instance, in 2016, Alcon announced their support to a public awareness program, Think About Your Eyes. The company committed USD 4 million to support this initiative and to promote awareness pertaining to vision care.

Further key findings from the study suggest:

• Anti-VEGF agents dominated the drug class segment in 2019 and is anticipated to register the fastest CAGR of 6.7% over the forecast period

• Retinal disorder held the largest market share in 2019 due to rising prevalence of diabetic retinopathy

• In 2019, macular degeneration was the largest retinal disorder segment and diabetic retinopathy was the fastest growing segment

• Eye drops held the leading ophthalmic drugs market share in 2019 and is projected to witness the highest CAGR during the forecast period as it is the most preferred form of drug delivery used for treating ocular diseases such as acute allergies, corneal ulcers, and glaucoma

• In 2019, topical route was the largest segment as it is non-invasive route of administration with high patient compliance

• The local ocular route is estimated to be the fastest growing segment over the forecast period

• Prescription drugs held the largest share in 2019 since it is considered to be more effective treatment

• North America led the market for ophthalmic drugs in 2019 due to high disease burden

• Asia Pacific is estimated to be the fastest growing market during the forecast period owing to rising disposable income along with growing awareness regarding various ophthalmic diseases

• Some of the key companies operating in the market are Novartis AG; Allergan PLC; Bausch & Lomb, Inc.; Pfizer, Inc.; Santen Pharmaceutical Co., Ltd.; Regeneron, Bayer AG; and Genentech, Inc.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Market definition
1.3. Information procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources & third party perspectives
1.3.4. Primary research
1.4. Information analysis
1.4.1. Data analysis models
1.5. Market formulation & data visualization
1.6. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Global Ophthalmic Drugs Market Variables, Trends & Scope
3.1. Ophthalmic Drugs Market Lineage outlook
3.1.1. Parent market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Pipeline Analysis
3.4. Cost Structure Analysis
3.5. Patent Expiry Scenario
3.6. Epidemiology
3.7. Regulatory Framework
3.8. User Perspective Analysis
3.9. Unmet Need Analysis
3.10. Primary Research Analysis
3.10.1. Factors estimated to impact on market growth
3.10.2. Market scenario
3.10.3. Key KOL responses
3.11. Market Dynamics
3.11.1. Market Driver Analysis
3.11.1.1. Increasing incidence and prevalence of eye related disorders
3.11.1.2. Increasing R & D pertaining to the development of novel drugs
3.11.1.3. Presence of strong emerging pipeline drugs
3.11.1.4. Increased funding from both public and private research organizations
3.11.2. Market Restraint Analysis
3.11.2.1. Loss of patent protection for blockbuster drugs
3.12. Ophthalmic Drugs Market Analysis Tools
3.12.1. Industry Analysis – Porter’s
3.12.1.1. Supplier Power: Low due to large number of manufacturers
3.12.1.2. Buyer Power: high due to increasing prevalence of eye related diseases
3.12.1.3. Substitution Threat: High due to presence external substitutes
3.12.1.4. Threat from new entrant: Moderate due to brand recognition of the existing players
3.12.1.5. Competitive rivalry: High due to rigorous competition among key players
3.13. PESTEL Analysis
3.13.1. Political Landscape
3.13.2. Environmental Landscape
3.13.3. Social Landscape
3.13.4. Technology Landscape
3.13.5. Legal Landscape
3.14. Major Deals & Strategic Alliances Analysis
3.14.1. Joint Ventures
3.14.2. Mergers & Acquisitions
3.14.3. Licensing & Partnership
3.14.4. Technology Collaborations
3.14.5. Strategic Divestments
Chapter 4. Ophthalmic Drugs Market – Competitive Analysis
4.1. Recent developments & impact analysis, by key market participants
4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3. Public Companies
4.3.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
4.3.2. Company Market Share/Ranking, by region
4.3.3. Competitive Dashboard Analysis
4.3.4. Market Differentiators
4.3.5. Synergy Analysis: Major Deals & Strategic Alliances
4.4. Private Companies
4.4.1. List of key emerging companies
4.4.2. Regional network map
4.4.3. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
Chapter 5. Ophthalmic Drugs Market: Drug Class Estimates & Trend Analysis
5.1. Definitions & Scope
5.2. Drug Class Market Share Analysis, 2019 & 2027
5.3. Drug Class Dashboard
5.4. Global Ophthalmic Drugs Market, by Drug Class, 2015 to 2027
5.5. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
5.5.1. Antiallergy
5.5.1.1. Antiallergy market, 2015 – 2027 (USD Million)
5.5.2. Anti-VEGF agents
5.5.2.1. Anti-VEGF market, 2015 – 2027 (USD Million)
5.5.3. Anti-inflammatory
5.5.3.1. Anti-inflammatory market, 2015 – 2027 (USD Million)
5.5.3.2. Nonsteroidal drugs
5.5.3.2.1. Nonsteroidal market, 2015 – 2027 (USD Million)
5.5.3.3. Steroidal drugs
5.5.3.3.1. Steroidal market, 2015 – 2027 (USD Million)
5.5.4. Antiglaucoma
5.5.4.1. Antiglaucoma market, 2015 – 2027 (USD Million)
5.5.5. Others
5.5.5.1. Others market, 2015 – 2027 (USD Million)
Chapter 6. Ophthalmic Drugs Market: Disease Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. Disease Market Share Analysis, 2019 & 2027
6.3. Disease Dashboard
6.4. Global Ophthalmic Drugs Market, by Disease, 2015 to 2027
6.5. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
6.5.1. Dry Eye
6.5.1.1. Dry eye market, 2015 – 2027 (USD Million)
6.5.2. Eye Allergy
6.5.2.1. Eye allergy market, 2015 – 2027 (USD Million)
6.5.3. Glaucoma
6.5.3.1. Glaucoma market, 2015 – 2027 (USD Million)
6.5.4. Eye Infection
6.5.4.1. Eye infection market, 2015 – 2027 (USD Million)
6.5.5. Retinal Disorders
6.5.5.1. Retinal disorders market, 2015 – 2027 (USD Million)
6.5.5.2. Macular Degeneration
6.5.5.2.1. Macular degeneration market, 2015 – 2027 (USD Million)
6.5.5.3. Diabetic Retinopathy
6.5.5.3.1. Diabetic retinopathy market, 2015 – 2027 (USD Million)
6.5.5.4. Others
6.5.5.4.1. Others market, 2015 – 2027 (USD Million)
6.5.6. Uveitis
6.5.6.1. Uveitis market, 2015 – 2027 (USD Million)
Chapter 7. Ophthalmic Drugs Market: Dosage Form Estimates & Trend Analysis
7.1. Definitions & Scope
7.2. Dosage Form Market Share Analysis, 2019 & 2027
7.3. Dosage Form Dashboard
7.4. Global Ophthalmic Drugs Market, by Dosage Form, 2015 to 2027
7.5. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
7.5.1. Gels
7.5.1.1. Gels market, 2015 – 2027 (USD Million)
7.5.2. Eye solutions
7.5.2.1. Eye solutions market, 2015 – 2027 (USD Million)
7.5.3. Capsules & Tablets
7.5.3.1. Capsules & tablets market, 2015 – 2027 (USD Million)
7.5.4. Eye drops
7.5.4.1. Eye drops market, 2015 – 2027 (USD Million)
7.5.5. Ointments
7.5.5.1. Ointments market, 2015 – 2027 (USD Million)
Chapter 8. Ophthalmic Drugs Market: Route of Administration Estimates & Trend Analysis
8.1. Definitions & Scope
8.2. Route of Administration Market Share Analysis, 2019 & 2027
8.3. Route of Administration Dashboard
8.4. Global Ophthalmic Drugs Market, by Route of Administration, 2015 to 2027
8.5. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
8.5.1. Topical
8.5.1.1. Topical market, 2015 – 2027 (USD Million)
8.5.2. Local Ocular
8.5.2.1. Local Ocular market, 2015 – 2027 (USD Million)
8.5.2.2. Subconjunctival
8.5.2.2.1. Subconjunctival market, 2015 – 2027 (USD Million)
8.5.2.3. Intravitreal
8.5.2.3.1. Intravitreal market, 2015 – 2027 (USD Million)
8.5.2.4. Retrobulbar
8.5.2.4.1. Retrobulbar market, 2015 – 2027 (USD Million)
8.5.2.5. Intracameral
8.5.2.5.1. Intracameral market, 2015 – 2027 (USD Million)
Chapter 9. Ophthalmic Drugs Market: Product Type Estimates & Trend Analysis
9.1. Definitions & Scope
9.2. Product Type Market Share Analysis, 2019 & 2027
9.3. Product Type Dashboard
9.4. Global Ophthalmic Drugs Market, by Product Type, 2015 to 2027
9.5. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
9.5.1. Prescription drugs
9.5.1.1. Prescription drugs market, 2015 – 2027 (USD Million)
9.5.2. OTC drugs
9.5.2.1. OTC drugs market, 2015 – 2027 (USD Million)
Chapter 10. Ophthalmic Drugs Market: Regional Estimates & Trend analysis, by Disease, Dosage Form, Product Type, Drug Class, And Route of Administration:
10.1. Regional Market Snapshot
10.2. Regional Market Share and Leading Players, 2019
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Latin America
10.3.5. Middle East & Africa
10.4. Market Size, & Forecasts, and Trend Analysis, 2019 to 2027:
10.4.1. North America
10.4.1.1. North America ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.1.2. U.S.
10.4.1.2.1. U.S. ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.1.3. Canada
10.4.1.3.1. Canada ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.2. Europe
10.4.2.1. Europe ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.2.2. U.K.
10.4.2.2.1. U.K. ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.2.3. Germany
10.4.2.3.1. Germany ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.2.4. Spain
10.4.2.4.1. Spain ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.2.5. France
10.4.2.5.1. France ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.2.6. Italy
10.4.2.6.1. Italy ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.2.7. Russia
10.4.2.7.1. Russia ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.3. Asia Pacific
10.4.3.1. Asia Pacific ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.3.2. China
10.4.3.2.1. China ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.3.3. Japan
10.4.3.3.1. Japan ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.3.4. India
10.4.3.4.1. India ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.3.5. South Korea
10.4.3.5.1. South Korea ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.3.6. Singapore
10.4.3.6.1. Singapore ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.3.7. Australia
10.4.3.7.1. Australia ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.4. Latin America
10.4.4.1. Latin America ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.4.2. Brazil
10.4.4.2.1. Brazil ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.4.3. Mexico
10.4.4.3.1. Mexico ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.4.4. Argentina
10.4.4.4.1. Argentina ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.5. Middle East Africa
10.4.5.1. MEA ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.5.2. South Africa
10.4.5.2.1. South Africa ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.5.3. Saudi Arabia
10.4.5.3.1. Saudi Arabia ophthalmic drugs market, 2015 – 2027 (USD Million)
10.4.5.4. UAE
10.4.5.4.1. UAE ophthalmic drugs market, 2015 – 2027 (USD Million)
Chapter 11. Company Profiles
11.1. Alcon
11.1.1. Company overview
11.1.2. Financial framework
11.1.3. Product benchmarking
11.1.4. Geographic footprint
11.1.5. Strategic initiatives
11.2. Novartis AG
11.2.1. Company overview
11.2.2. Financial framework
11.2.3. Product benchmarking
11.2.4. Geographic footprint
11.2.5. Strategic initiatives
11.3. Johnson & Johnson Services Inc.
11.3.1. Company overview
11.3.2. Financial framework
11.3.3. Product benchmarking
11.3.4. Geographic footprint
11.3.5. Strategic initiatives
11.4. Merck Sharp & Dohme Corp.
11.4.1. Company overview
11.4.2. Financial framework
11.4.3. Product benchmarking
11.4.4. Geographic footprint
11.4.5. Strategic initiatives
11.5. Regeneron
11.5.1. Company overview
11.5.2. Financial framework
11.5.3. Product benchmarking
11.5.4. Geographic footprint
11.5.5. Strategic initiatives
11.6. ALLERGAN
11.6.1. Company overview
11.6.2. Financial framework
11.6.3. Product benchmarking
11.6.4. Geographic footprint
11.6.5. Strategic initiatives
11.7. Pfizer, Inc.
11.7.1. Company overview
11.7.2. Financial framework
11.7.3. Product benchmarking
11.7.4. Geographic footprint
11.7.5. Strategic initiatives
11.8. Bausch Health
11.8.1. Company overview
11.8.2. Financial framework
11.8.3. Product benchmarking
11.8.4. Geographic footprint
11.8.5. Strategic initiatives
11.9. Bayer AG
11.9.1. Company overview
11.9.2. Financial framework
11.9.3. Product benchmarking
11.9.4. Geographic footprint
11.9.5. Strategic initiatives
11.10. Santen Pharmaceutical Co., Ltd
11.10.1. Company overview
11.10.2. Financial framework
11.10.3. Product benchmarking
11.10.4. Geographic footprint
11.10.5. Strategic initiatives
11.11. Genentech, Inc.
11.11.1. Company overview
11.11.2. Financial framework
11.11.3. Product benchmarking
11.11.4. Geographic footprint
11.11.5. Strategic initiatives

List of Tables

1. Europe MRO distribution market estimates and forecasts, by bearings & power transmission products, 2016 - 2027 (USD Million)
2. Europe MRO distribution market estimates and forecasts, by pipes, valves, & fittings products, 2016 - 2027 (USD Million)
3. Europe MRO distribution market estimates and forecasts, by electrical items, 2016 - 2027 (USD Million)
4. Europe MRO distribution market estimates and forecasts, by packaging supplies, 2016 - 2027 (USD Million)
5. Europe MRO distribution market estimates and forecasts, by machine consumables, 2016 - 2027 (USD Million)
6. Europe MRO distribution market estimates and forecasts, by internal MRO sourcing/service, 2016 - 2027 (USD Million)
7. Europe MRO distribution market estimates and forecasts, by external MRO sourcing/service, 2016 - 2027 (USD Million)
8. Europe MRO distribution Market estimates and forecasts, by preventive/scheduled maintenance, 2016 - 2027 (USD Million)
9. Europe MRO distribution Market estimates and forecasts, by corrective maintenance, 2016 - 2027 (USD Million)
10. Europe MRO distribution Market estimates and forecasts, by direct distribution channel, 2016 - 2027 (USD Million)
11. Europe MRO distribution Market estimates and forecasts, by indirect distribution channel, 2016 - 2027 (USD Million)
12. Europe MRO distribution Market estimates and forecasts, in food, beverage & tobacco, 2016 - 2027 (USD Million)
13. Europe MRO distribution Market estimates and forecasts, in textile, apparel & footwear, 2016 - 2027 (USD Million)
14. Europe MRO distribution Market estimates and forecasts, in wood & paper, 2016 - 2027 (USD Million)
15. Europe MRO distribution Market estimates and forecasts, in mining, oil & gas, 2016 - 2027 (USD Million)
16. Europe MRO distribution Market estimates and forecasts, in basic metals & metal products, 2016 - 2027 (USD Million)
17. Europe MRO distribution Market estimates and forecasts, in rubber, plastic and non-metallic products, 2016 - 2027 (USD Million)
18. Europe MRO distribution Market estimates and forecasts, in chemical, 2016 - 2027 (USD Million)
19. Europe MRO distribution market estimates and forecasts, in pharmaceuticals, 2016 - 2027 (USD Million)
20. Europe MRO distribution market estimates and forecasts, in electronics, 2016 - 2027 (USD Million)
21. Europe MRO distribution market estimates and forecasts, in machinery and equipment, 2016 - 2027 (USD Million)
22. Europe MRO distribution market estimates and forecasts, in electrical equipment, 2016 - 2027 (USD Million)
23. Europe MRO distribution market estimates and forecasts, in transport equipment, 2016 - 2027 (USD Million)
24. Europe MRO distribution market estimates and forecasts, in manufacturing, 2016 - 2027 (USD Million)
25. Czech Republic MRO distribution market estimates and forecasts, 2016 - 2027 (USD Million)
26. Czech Republic MRO distribution market estimates and forecasts, by product, 2016 - 2027 (USD Million)
27. Czech Republic MRO distribution market estimates and forecasts, by sourcing/service, 2016 - 2027 (USD Million)
28. Czech Republic MRO distribution market estimates and forecasts, by maintenance type, 2016 - 2027 (USD Million)
29. Czech Republic MRO distribution market estimates and forecasts, by distribution channel, 2016 - 2027 (USD Million)
30. Czech Republic MRO distribution market estimates and forecasts, by application, 2016 - 2027 (USD Million)
31. Hungary MRO distribution market estimates and forecasts, 2016 - 2027 (USD Million)
32. Hungary MRO distribution market estimates and forecasts, by product, 2016 - 2027 (USD Million)
33. Hungary MRO distribution market estimates and forecasts, by sourcing/service, 2016 - 2027 (USD Million)
34. Hungary MRO distribution market estimates and forecasts, by maintenance type, 2016 - 2027 (USD Million)
35. Hungary MRO distribution market estimates and forecasts, by distribution channel, 2016 - 2027 (USD Million)
36. Hungary MRO distribution market estimates and forecasts, by application, 2016 - 2027 (USD Million)
37. Slovakia MRO distribution market estimates and forecasts, 2016 - 2027 (USD Million)
38. Slovakia MRO distribution market estimates and forecasts, by product, 2016 - 2027 (USD Million)
39. Slovakia MRO distribution market estimates and forecasts, by sourcing/service, 2016 - 2027 (USD Million)
40. Slovakia MRO distribution market estimates and forecasts, by maintenance type, 2016 - 2027 (USD Million)
41. Slovakia MRO distribution market estimates and forecasts, by distribution channel, 2016 - 2027 (USD Million)
42. Slovakia MRO distribution market estimates and forecasts, by application, 2016 - 2027 (USD Million)
43. Austria MRO distribution market estimates and forecasts, 2016 - 2027 (USD Million)
44. Austria MRO distribution market estimates and forecasts, by product, 2016 - 2027 (USD Million)
45. Austria MRO distribution market estimates and forecasts, by sourcing/service, 2016 - 2027 (USD Million)
46. Austria MRO distribution market estimates and forecasts, by maintenance type, 2016 - 2027 (USD Million)
47. Austria MRO distribution market estimates and forecasts, by distribution channel, 2016 - 2027 (USD Million)
48. Austria MRO distribution market estimates and forecasts, by application, 2016 - 2027 (USD Million)
49. Finland MRO distribution market estimates and forecasts, 2016 - 2027 (USD Million)
50. Finland MRO distribution market estimates and forecasts, by product, 2016 - 2027 (USD Million)
51. Finland MRO distribution market estimates and forecasts, by sourcing/service, 2016 - 2027 (USD Million)
52. Finland MRO distribution market estimates and forecasts, by maintenance type, 2016 - 2027 (USD Million)
53. Finland MRO distribution market estimates and forecasts, by distribution channel, 2016 - 2027 (USD Million)
54. Finland MRO distribution market estimates and forecasts, by application, 2016 - 2027 (USD Million)
55. France MRO distribution market estimates and forecasts, 2016 - 2027 (USD Million)
56. France MRO distribution market estimates and forecasts, by product, 2016 - 2027 (USD Million)
57. France MRO distribution market estimates and forecasts, by sourcing/service, 2016 - 2027 (USD Million)
58. France MRO distribution market estimates and forecasts, by maintenance type, 2016 - 2027 (USD Million)
59. France MRO distribution market estimates and forecasts, by distribution channel, 2016 - 2027 (USD Million)
60. France MRO distribution market estimates and forecasts, by application, 2016 - 2027 (USD Million)
61. Germany MRO distribution market estimates and forecasts, 2016 - 2027 (USD Million)
62. Germany MRO distribution market estimates and forecasts, by product, 2016 - 2027 (USD Million)
63. Germany MRO distribution market estimates and forecasts, by sourcing/service, 2016 - 2027 (USD Million)
64. Germany MRO distribution market estimates and forecasts, by maintenance type, 2016 - 2027 (USD Million)
65. Germany MRO distribution market estimates and forecasts, by distribution channel, 2016 - 2027 (USD Million)
66. Germany MRO distribution market estimates and forecasts, by application, 2016 - 2027 (USD Million)
67. Italy MRO distribution market estimates and forecasts, 2016 - 2027 (USD Million)
68. Italy MRO distribution market estimates and forecasts, by product, 2016 - 2027 (USD Million)
69. Italy MRO distribution market estimates and forecasts, by sourcing/service, 2016 - 2027 (USD Million)
70. Italy MRO distribution market estimates and forecasts, by maintenance type, 2016 - 2027 (USD Million)
71. Italy MRO distribution market estimates and forecasts, by distribution channel, 2016 - 2027 (USD Million)
72. Italy MRO distribution market estimates and forecasts, by application, 2016 - 2027 (USD Million)
73. Belgium MRO distribution market estimates and forecasts, 2016 - 2027 (USD Million)
74. Belgium MRO distribution market estimates and forecasts, by product, 2016 - 2027 (USD Million)
75. Belgium MRO distribution market estimates and forecasts, by sourcing/service, 2016 - 2027 (USD Million)
76. Belgium MRO distribution market estimates and forecasts, by maintenance type, 2016 - 2027 (USD Million)
77. Belgium MRO distribution market estimates and forecasts, by distribution channel, 2016 - 2027 (USD Million)
78. Belgium MRO distribution market estimates and forecasts, by application, 2016 - 2027 (USD Million)
79. Netherlands MRO distribution market estimates and forecasts, 2016 - 2027 (USD Million)
80. Netherlands MRO distribution market estimates and forecasts, by product, 2016 - 2027 (USD Million)
81. Netherlands MRO distribution market estimates and forecasts, by sourcing/service, 2016 - 2027 (USD Million)
82. Netherlands MRO distribution market estimates and forecasts, by maintenance type, 2016 - 2027 (USD Million)
83. Netherlands MRO distribution market estimates and forecasts, by distribution channel, 2016 - 2027 (USD Million)
84. Netherlands MRO distribution market estimates and forecasts, by application, 2016 - 2027 (USD Million)
85. Poland MRO distribution market estimates and forecasts, 2016 - 2027 (USD Million)
86. Poland MRO distribution market estimates and forecasts, by product, 2016 - 2027 (USD Million)
87. Poland MRO distribution market estimates and forecasts, by sourcing/service, 2016 - 2027 (USD Million)
88. Poland MRO distribution market estimates and forecasts, by maintenance type, 2016 - 2027 (USD Million)
89. Poland MRO distribution market estimates and forecasts, by distribution channel, 2016 - 2027 (USD Million)
90. Poland MRO distribution market estimates and forecasts, by application, 2016 - 2027 (USD Million)
91. Sweden MRO distribution market estimates and forecasts, 2016 - 2027 (USD Million)
92. Sweden MRO distribution market estimates and forecasts, by product, 2016 - 2027 (USD Million)
93. Sweden MRO distribution market estimates and forecasts, by sourcing/service, 2016 - 2027 (USD Million)
94. Sweden MRO distribution market estimates and forecasts, by maintenance type, 2016 - 2027 (USD Million)
95. Sweden MRO distribution market estimates and forecasts, by distribution channel, 2016 - 2027 (USD Million)
96. Sweden MRO distribution market estimates and forecasts, by application, 2016 - 2027 (USD Million)
97. Denmark MRO distribution market estimates and forecasts, 2016 - 2027 (USD Million)
98. Denmark MRO distribution market estimates and forecasts, by product, 2016 - 2027 (USD Million)
99. Denmark MRO distribution market estimates and forecasts, by sourcing/service, 2016 - 2027 (USD Million)
100. Denmark MRO distribution market estimates and forecasts, by maintenance type, 2016 - 2027 (USD Million)
101. Denmark MRO distribution market estimates and forecasts, by distribution channel, 2016 - 2027 (USD Million)
102. Denmark MRO distribution market estimates and forecasts, by application, 2016 - 2027 (USD Million)
103. Switzerland MRO distribution market estimates and forecasts, 2016 - 2027 (USD Million)
104. Switzerland MRO distribution market estimates and forecasts, by product, 2016 - 2027 (USD Million)
105. Switzerland MRO distribution market estimates and forecasts, by sourcing/service, 2016 - 2027 (USD Million)
106. Switzerland MRO distribution market estimates and forecasts, by maintenance type, 2016 - 2027 (USD Million)
107. Switzerland MRO distribution market estimates and forecasts, by distribution channel, 2016 - 2027 (USD Million)
108. Switzerland MRO distribution market estimates and forecasts, by application, 2016 - 2027 (USD Million)

List of Figures

1. Information Procurement
2. Primary Research Pattern
3. Primary Research Process
4. Market research approaches - Bottom Up Approach
5. Market research approaches - Top Down Approach
6. Market research approaches - Combined Approach
7. Europe MRO distribution market - Penetration & Growth Prospect Mapping
8. Europe MRO distribution market - Value chain analysis
9. Europe MRO distribution: Market dynamics
10. Europe MRO distribution market driver impact analysis
11. Europe MRO distribution market driver impact
12. Europe MRO distribution market: Product movement analysis, 2019 & 2027
13. Europe MRO distribution market: Sourcing/Service movement analysis, 2019 & 2027
14. Europe MRO distribution market: Maintenance type movement analysis, 2019 & 2027
15. Europe MRO distribution market: Distribution channel movement analysis, 2019 & 2027
16. Europe MRO distribution market: Application movement analysis, 2019 & 2027
17. Europe MRO Distribution market - Company Categorization

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[眼科用医薬品の世界市場：薬物クラス別、疾患別、剤形別、投与経路別、製品タイプ別、地域別]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. ベータラクタム及びベータラクタマーゼ阻害剤の世界市場：薬物クラス別、疾患別、投与経路別
    AMR9NV046 / Allied Market Research / 2019年8月 / 当調査レポートでは、ベータラクタム及びベータラクタマーゼ阻害剤の世界市場について調査・分析し、市場概要、薬物クラス別（ペニシリン、セファロスポリン、カルバペネム、モノバクタム、組み合わせ）分析、疾患別（尿路感染症、呼吸器感染症、皮膚感染症、合併症のある尿路感染症（cUTI）、合併症のある腹腔内感染症（cIAI）、院内肺炎、血流感染症、その他の疾患）分析、投与経路別（経口、静脈内、その他の投与経路）分析、地域別分析、企業動向など含め、以下の構成でお届け致します。 ・イントロダクション ・エグゼクティブサマリー ・市場概要 ・ベータラクタム及びベータラクタマーゼ阻害剤の世界市場：薬物クラス別（ペニシリン、セファロスポリン、カルバペネム、モノバクタム、組み合わせ） ・ベータラクタム及びベータラクタマーゼ阻害剤の世界市場：疾患別（尿路感染症、呼吸器感染症、皮膚感染症、合併症のある尿路感染症（cUTI）、合併症のある腹腔内感染症（cIAI）、院内肺炎、血流感染症、その他の疾患） ・ベータラクタム及びベータラクタマーゼ阻害剤の世界市場：投与経路別（経口、静脈内、その他の投与経路） ・ベータラクタム及びベータラクタマーゼ阻害剤の世界市場：地域別 ・企業動向 ...The global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. Beta-lactam and beta-lactamase inhibitors is a most important type of antibacterial agent used for fighting bacterial infections. In addition, these are used to kill or prevent the growth of microorganisms. Based on the molecular structure, beta-lactam and beta-lactamase inhibitors are drug classified into penicillin, cephalosporin, carbapenem, monobactam, and combination. There is an increase in the demand for beta-lactam and beta-lactamase inhibitors, owing to increased consumption in low- and...
  2. 気管支拡張薬の世界市場：薬物クラス別（交感神経刺激薬、抗コリン作用薬、ホスホジエステラーゼ阻害薬、配合剤）、疾患別（喘息、COPD、その他）、投与経路別（経口、注射、吸入器）
    AMR20MY0115 / Allied Market Research / 2020年2月 / 本調査レポートでは、気管支拡張薬の世界市場について調査・分析を行い、イントロダクション、エグゼクティブサマリー、市場概要、疾患別（喘息、COPD、その他）分析、薬物クラス別（交感神経刺激薬、抗コリン作用薬、ホスホジエステラーゼ阻害薬、配合剤）分析、投与経路別（経口、注射、吸入器）分析、地域別分析、企業概要などを含め、今後の方向性を明らかに致します。 ・イントロダクション ・エグゼクティブサマリ－ ・市場概要 ・気管支拡張薬の世界市場：疾患別（喘息、COPD、その他） ・気管支拡張薬の世界市場：薬物クラス別（交感神経刺激薬、抗コリン作用薬、ホスホジエステラーゼ阻害薬、配合剤） ・気管支拡張薬の世界市場：投与経路別（経口、注射、吸入器） ・気管支拡張薬の世界市場：地域別 ・企業概要...The global bronchodilators market was valued at $27,580.00 million in 2018 and is expected to reach $41,487.53 million by 2026, registering a CAGR of 5.2% from 2019 to 2026. Bronchodilators are drugs that relax muscles that tighten around the airways. These drugs open airways and allow more air to move in and out of lungs. They are also used to reduce mucus from lungs. Patients suffering from respiratory disorders consume these drugs through the help of nebulizers or inhalers. In addition, inhaler bronchodilators have effects on mucociliary clearance as well. Bronchodilators are used in the treatment of obstructive lung diseases...
  3. 嚢胞性線維症（CF）治療薬の世界市場：薬物クラス別（膵酵素サプリメント、粘液溶解薬、気管支拡張薬、CFTRモジュレーター）、投与経路別（経口、吸入）
    AMR20JN031 / Allied Market Research / 2019年11月30日 / 本市場調査レポートでは嚢胞性線維症（CF）治療薬について、イントロダクション、エグゼクティブサマリー、市場概要、薬物クラス別（膵酵素サプリメント、粘液溶解薬、気管支拡張薬、CFTRモジュレーター）分析、投与経路別（経口、吸入）分析、地域別分析、企業概要に区分して収録しています。 ・イントロダクション ・エグゼクティブサマリー ・市場概要 ・嚢胞性線維症（CF）治療薬の世界市場：薬物クラス別（膵酵素サプリメント、粘液溶解薬、気管支拡張薬、CFTRモジュレーター） ・嚢胞性線維症（CF）治療薬の世界市場：投与経路別（経口、吸入） ・嚢胞性線維症（CF）治療薬の世界市場：地域別 ・企業概要 ...The global cystic fibrosis therapeutics market was valued at $4,615.4 million in 2018 and is expected to reach $9,277.3 million by 2026, registering a CAGR of 9.2% from 2019 to 2026. Cystic fibrosis is a progressive, hereditary disease that led to insistent lung infections and limits the patient’s ability to breathe over time. Diagnosis of cystic fibrosis is a multistep process, and includes a newborn screening, a sweat test, a genetic or carrier test, and a clinical evaluation. Though people diagnosed with the disease are of age of 2, some are also diagnosed as adults. A specialist can order a...
  4. 骨粗鬆症治療薬の世界市場：薬物クラス別（ビスホスホネート、選択的エストロゲン阻害剤モジュレーター（SERM）、副甲状腺ホルモン療法、カルシトニン、RANKLリガンド阻害剤、その他）、投与経路別
    AMR20JN084 / Allied Market Research / 2020年3月 / 本調査レポートでは、骨粗鬆症治療薬の世界市場を調査・分析することにより、イントロダクション、エグゼクティブサマリー、市場概要、薬物クラス別（ビスホスホネート、選択的エストロゲン阻害剤モジュレーター（SERM）、副甲状腺ホルモン療法、カルシトニン、RANKLリガンド阻害剤、その他）分析、投与経路別分析、地域別、企業情報と今後の方向性を明らかに致します。 ・イントロダクション ・エグゼクティブサマリー ・市場概要 ・骨粗鬆症治療薬の世界市場：薬物クラス別（ビスホスホネート、選択的エストロゲン阻害剤モジュレーター（SERM）、副甲状腺ホルモン療法、カルシトニン、RANKLリガンド阻害剤、その他） ・骨粗鬆症治療薬の世界市場：投与経路別 ・地域別 ・企業情報...The global osteoporosis drugs market accounted for $7,657 million in 2018, and is expected to reach $10,479 million by 2026, registering a CAGR of 3.9% from 2019 to 2026. Osteoporosis drugs are defined as therapeutic agents which are utilized in the treatment of osteoporosis. Furthermore, osteoporosis is a serious medical condition which is associated with the presence of fragile bones. In addition, these fragile bones are dense and prone to fractures. Moreover, the condition is caused due to the over production of hormone parathyroid and leads to limited mobility in patients suffering from the condition. Thus, this medical condition requires...
  5. アンドロゲン欠乏療法（ADT）の世界市場：薬物クラス別（抗アンドロゲン、LHRHアゴニスト、LHRH拮抗薬、その他）、投与経路別（経口、注射）、流通経路別（病院、小売薬局、オンライン薬局）、地域別
    BZW20AP030 / Bizwit Research & Consulting / 2020年2月6日 / 本調査レポートでは、アンドロゲン欠乏療法（ADT）の世界市場について、エグゼクティブサマリー、市場の定義・範囲、市場動向、産業分析、薬物クラス別（抗アンドロゲン、LHRHアゴニスト、LHRH拮抗薬、その他）分析、投与経路別（経口、注射）分析、流通経路別（病院、小売薬局、オンライン薬局）分析、地域別分析、競争状況などを総合的、多面的に調査・分析しております。 ・エグゼクティブサマリー ・市場の定義・範囲 ・市場動向 ・産業分析 ・アンドロゲン欠乏療法（ADT）の世界市場：薬物クラス別（抗アンドロゲン、LHRHアゴニスト、LHRH拮抗薬、その他） ・アンドロゲン欠乏療法（ADT）の世界市場：投与経路別（経口、注射） ・アンドロゲン欠乏療法（ADT）の世界市場：流通経路別（病院、小売薬局、オンライン薬局） ・アンドロゲン欠乏療法（ADT）の世界市場：地域別 ・競争状況...Global Androgen Deprivation Therapy (ADT) Market is valued approximately at USD XX billion in 2018 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2019-2026. Androgen deprivation therapy (ADT) is a type of antihormone therapy which is primarily utilized in the cure of prostate cancer. Prostate cancer cells typically requires androgen hormones such as testosterone to grow. The use of androgen deprivation therapy reduces the level of androgen hormones, with surgery or drug delivery to prevent the prostate cells from rising. Various studies have determined that ADT has shown the benefits...
  6. クリーンルーム技術の世界市場：製品タイプ別（機器、消耗品）、最終用途別（医薬品、医療機器、バイオテクノロジー）、地域別
    GV20MY038 / Grand View Research / 2020年3月16日 / 本調査レポートでは、クリーンルーム技術の世界市場について調査・分析し、調査手法、エグゼクティブサマリー、産業概要、製品タイプ別（機器、消耗品）分析、最終用途別（医薬品、医療機器、バイオテクノロジー）分析、地域別分析、競争状況などの構成でお届けいたします。 ・調査手法 ・エグゼクティブサマリー ・産業概要 ・クリーンルーム技術の世界市場：製品タイプ別（機器、消耗品） ・クリーンルーム技術の世界市場：最終用途別（医薬品、医療機器、バイオテクノロジー） ・クリーンルーム技術の世界市場：地域別 ・競争状況...The global cleanroom technology market size is expected to reach USD 5.3 billion by 2027, expanding at a CAGR of 3.8%, according to a new report by Grand View Research, Inc. Technological advancement in cleanroom equipment, increasing need for cleanroom technology to develop quality products, and initiatives taken by private and public organizations to create awareness are key factors driving market growth. Manufacturing companies in various industries are dependent on cleanroom technology in order to comply with the stringent regulatory standards. Moreover, there has been an increase in need for standardizing cleanroom standards due to presence of a wide range...
  7. 生物学的安全キャビネットの世界市場2020-2027：製品タイプ別（クラスI、II、III）、最終用途別
    GV20JN094 / Grand View Research / 2020年5月 / 本調査レポートでは、生物学的安全キャビネットの世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、製品タイプ別（クラスI、II、III）分析、最終用途別分析、地域別分析、競争分析など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・生物学的安全キャビネットの世界市場規模：製品タイプ別（クラスI、II、III） ・生物学的安全キャビネットの世界市場規模：最終用途別 ・生物学的安全キャビネットの世界市場規模：地域別 ・競争分析...Biological Safety Cabinets Market Growth & Trends The global biological safety cabinets market size is expected to reach USD 282.1 million by 2027, registering a CAGR of 7.5%, according to a new report by Grand View Research, Inc. Technological advancements due to a rise in laboratory procedures performed that play a crucial role in the safety of personnel, product, and environment, have propelled the market growth. The introduction of smart biosafety cabinets, such as PureLogic+ manufactured by Labconco Inc., with new features and adjustable accessories is playing a crucial role in the growth of the market. To improve the safety,...
  8. ホルモン補充療法の世界市場：製品別（エストロゲン、人間成長）、投与経路別（経口、非経口）、疾患種類別、地域別
    GV20MY053 / Grand View Research / 2020年2月17日 / 本調査レポートでは、ホルモン補充療法の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、製品別（エストロゲンホルモン補充療法、HGH補充療法、甲状腺ホルモン補充療法、テストステロンホルモン補充療法）分析、投与経路別（経口、非経口、経皮、その他）分析、疾患種類別（更年期障害、甲状腺機能低下症、男性性腺機能低下症、成長ホルモン欠乏症、その他）分析、地域別分析、競争分析などの構成でお届けいたします。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・ホルモン補充療法の世界市場：製品別（エストロゲンホルモン補充療法、HGH補充療法、甲状腺ホルモン補充療法、テストステロンホルモン補充療法） ・ホルモン補充療法の世界市場：投与経路別（経口、非経口、経皮、その他） ・ホルモン補充療法の世界市場：疾患種類別（更年期障害、甲状腺機能低下症、男性性腺機能低下症、成長ホルモン欠乏症、その他） ・ホルモン補充療法の世界市場：地域別 ・競争分析...The global hormone replacement therapy market size is expected to reach USD 39.6 billion by 2027, expanding at a CAGR of 7.7%, according to a new report by Grand View Research, Inc. A significant rise in the incidence rate of hormonal disorders in the newborns, adults, and elderly and populations is driving the market. The Prader-Willi syndrome (PWS) affects one in every 15,000 newborns, thereby boosting the demand for the therapy. Estrogen replacement hormone therapy helps in reducing the vaginal indications of menopause, such as dryness, burning, itching, and pain during intercourse. Estrogen is available in the forms of pill,...
  9. 医療食品の世界市場：投与経路別（経口、経腸）、製品別（錠剤、粉末）、用途別、販売経路別（オンライン、機関、小売）
    GV20MY057 / Grand View Research / 2020年3月3日 / 本調査レポートでは、医療食品の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、競争分析、投与経路別（経口、経腸）分析、製品別（錠剤、粉末、その他）分析、用途別（慢性腎臓病、最小肝性脳症、化学療法誘発下痢、病原体関連感染症、糖尿病性神経障害、ADHD、うつ病、アルツハイマー病、栄養欠乏症、孤児病、その他）分析、地域別分析、企業概要などの構成でお届けいたします。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・競争分析 ・医療食品の世界市場：投与経路別（経口、経腸） ・医療食品の世界市場：製品別（錠剤、粉末、その他） ・医療食品の世界市場：用途別（慢性腎臓病、最小肝性脳症、化学療法誘発下痢、病原体関連感染症、糖尿病性神経障害、ADHD、うつ病、アルツハイマー病、栄養欠乏症、孤児病、その他） ・医療食品の世界市場：地域別 ・企業概要...The global medical foods market size is expected to reach USD 30.4 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 6.3% over the forecast period. This market is driven by rising geriatric population, increasing prevalence of chronic diseases, and growing focus of policymakers on the management of malnutrition. Dietary management of chronic diseases and rare disorders is the emerging focus area for manufacturers of medical foods, which is also positively impacting the market growth. Patients with chronic diseases develop nutritional deficiencies owing to adverse effects of the disease or the drugs...
  10. 光学前臨床画像の世界市場2020-2027：製品タイプ別（デバイス、消耗品、ソフトウェア）、最終用途別、地域別
    GV20JN103 / Grand View Research / 2020年4月 / 本調査レポートでは、光学前臨床画像の世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、製品タイプ別（デバイス、消耗品、ソフトウェア）分析、最終用途別分析、地域別分析、競争状況など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・光学前臨床画像の世界市場規模：製品タイプ別（デバイス、消耗品、ソフトウェア） ・光学前臨床画像の世界市場規模：最終用途別 ・光学前臨床画像の世界市場規模：地域別 ・競争状況...The global optical preclinical imaging market size is expected to reach USD 543.0 million by the end of 2027, expanding at a CAGR of 3.3%, according to a new report by Grand View Research, Inc. Increasing number of preclinical studies aimed to study and develop various effective therapeutics for different diseases is a major factor boosting the adoption of optical preclinical imaging systems. For instance, in December 2018, Bugworks Research, a drug discovery startup based in India, received US$ 3 million grant from CARB-X, a Boston-based organization. The grant was offered to support the development of preclinical trail for novel...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆